Oliver Luxxe Assets LLC
Source: SEC Form 13F · as of Mar 2026Oliver Luxxe Assets LLC holds 15 biotech & pharma companies tracked by BioSniper, totaling $47.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$47.5M
| Company | Shares | Value |
|---|---|---|
| PMPhilip Morris International Inc | 71,401 | $11.8M |
| GILDGILEAD SCIENCES, INC. | 53,158 | $7.4M |
| ABBVAbbVie Inc. | 33,630 | $7.3M |
| JAZZJazz Pharmaceuticals plc | 19,050 | $3.6M |
| REGNREGENERON PHARMACEUTICALS, INC. | 4,641 | $3.6M |
| HALOHALOZYME THERAPEUTICS, INC. | 50,180 | $3.2M |
| GMEDGlobus Medical Inc. | 28,906 | $2.5M |
| ANIPANI PHARMACEUTICALS INC | 31,520 | $2.4M |
| CPRXCATALYST PHARMACEUTICALS, INC. | 96,636 | $2.4M |
| INVAInnoviva, Inc. | 84,960 | $2.0M |
| PFEPFIZER INC | 18,762 | $527K |
| JNJJOHNSON & JOHNSON | 1,059 | $259K |
| AMGNAMGEN INC | 640 | $225K |
| MRKMerck & Co., Inc. | 1,679 | $202K |
| GANXGain Therapeutics, Inc. | 20,250 | $39K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.